Divi's Laboratories Ltd.

View in App
3539.90 +15.15 ▲0.4%

02 June 2023, 04:01:00 PM
Volume: 9,769

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.divislabs.com
Market Cap 93,340.08 Cr.
Enterprise Value(EV) 89,126.99 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 68.69 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 51.54 Trailing Twelve Months Ending 2023-03
Industry PE 33.43 Trailing Twelve Months Ending 2023-03
Book Value / Share 480.93 Trailing Twelve Months Ending 2023-03
Price to Book Value 7.36 Calculated using Price: 3,539.90
Dividend Yield 0.85 Period Ending 2022-03
No. of Shares Subscribed 26.55 Cr. 265,468,580 Shares
FaceValue 2
About Divi's Laboratories Ltd.
The Company is engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.

Divi's Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Divi's Laboratories Ltd. Performance

View details >>
1 Day
+0.43%
1 Week
+0.82%
1 Month
+8.80%
3 Month
+23.73%
6 Month
+4.72%
1 Year
+0.43%
2 Year
-16.00%
5 Year
+237.21%
10 Year
+626.68%

Divi's Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 28.31 26.37 28.91 21.98 15.55 21.00 19.30 23.90 28.16
Return on Capital Employed (%) 36.04 33.06 35.57 28.75 21.68 28.50 25.36 32.07 35.06
Return on Assets (%) 19.92 18.21 22.49 17.21 11.12 15.78 15.11 19.07 22.77

Divi's Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 2,963 3,495 4,293 5,357 5,925 6,957 7,310 9,295 11,728 12,767
Non Curr. Liab. 650 842 85 1,412 1,769 991 295 364 437 556
Curr. Liab. 627 776 520 659 653 847 1,821 1,728 2,454 1,101
Minority Int.
Equity & Liab. 4,241 5,112 4,898 7,429 8,347 8,795 9,425 11,387 14,619 14,425
Non Curr. Assets 1,984 2,340 1,871 3,418 3,812 4,145 3,851 4,596 5,009 5,113
Curr. Assets 2,256 2,772 3,027 4,011 4,535 4,650 5,574 6,791 9,610 9,312
Misc. Exp. not W/O
Total Assets 4,241 5,112 4,898 7,429 8,347 8,795 9,425 11,387 14,619 14,425

Divi's Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 2,532 3,115 3,776 4,064 3,891 4,946 5,394 6,969 8,960 7,768
Other Income 71 45 97 75 113 156 190 63 116 349
Total Income 2,603 3,160 3,874 4,139 4,005 5,102 5,584 7,032 9,076 8,116
Total Expenditure -1,517 -1,949 -2,358 -2,617 -2,629 -3,073 -3,571 -4,108 -5,079 -5,404
PBIDT 1,086 1,211 1,516 1,522 1,376 2,029 2,013 2,924 3,997 2,712
Interest -3 -3 -5 -3 -2 -5 -7 -2 -2 -1
Depreciation -92 -136 -118 -123 -142 -169 -186 -256 -312 -343
Taxation -218 -221 -267 -335 -354 -502 -443 -682 -723 -545
Exceptional Items
PAT 773 852 1,126 1,060 877 1,353 1,377 1,984 2,960 1,823
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 773 852 1,126 1,060 877 1,353 1,377 1,984 2,960 1,823
Adjusted EPS 29 32 42 40 33 51 52 75 112 69

Divi's Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 480 557 826 1,038 1,150 776 954 1,216 1,947 1,912
Cash Fr. Inv. -255 -305 -521 -406 -1,140 -478 -685 -83 75 -2,195
Cash Fr. Finan. -231 -249 -303 -631 2 -314 -246 -1,091 -35 -532
Net Change -5 3 3 0 13 -17 23 41 1,987 -816
Cash & Cash Eqvt 12 15 18 18 -4 -21 2 43 2,030 1,215

Divi's Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 51.95 51.95 51.95 51.95 51.94 51.94 51.94 51.94 51.94
Public 48.05 48.05 48.05 48.05 48.06 48.06 48.06 48.06 48.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Divi's Laboratories Ltd. Announcements

View details >>
Thu, 25 May 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
We hereby submit the transcript of the earnings conference call for the quarter and year ended March 31 2023 held on May 20 2023 at 14.00 Hrs IST. The transcript is also available on the website of the Company i.e. www.divislabs.com under Investors Relations section.
Tue, 23 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby submit the Annual Secretarial Compliance Report for the year ended March 31 2023 issued by Mr. V. Bhaskara Rao Practicing Company Secretary Hyderabad.
Mon, 22 May 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose herewith copies of newspapers publication regarding extracts of audited financial results of the Company for the quarter and year ended March 31 2023. This notice is published on May 21 2023 in Financial Express (English daily - All editions) and Andhra Prabha (Telugu daily - Hyderabad edition).

Divi's Laboratories Ltd. Technical Scans

View details >>
Fri, 02 Jun 2023
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 5 Years High Increase in 5 Years
CCI Overbought Zone CCI Overbought Zone

Divi's Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 239,777.54 999.35 +1.2%
Cipla Ltd. 77,917.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. 76,753.53 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. 71,422.15 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. 60,134.99 1,774.00 -0.1%
Mankind Pharma Ltd. 58,728.27 1,466.05 +4.9%
Zydus Lifesciences Ltd. 52,487.85 519.40 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.30 999.35 +1.2%
Cipla Ltd. Consolidated 2023-03 27.85 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.03 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 87.03 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.23 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 26.82 519.40 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.28 999.35 +1.2%
Cipla Ltd. Consolidated 2023-03 3.33 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.52 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 3.00 519.40 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 999.35 +1.2%
Cipla Ltd. Consolidated 2022-03 0.04 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 519.40 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 519.40 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 999.35 +1.2%
Cipla Ltd. Consolidated 2022-03 13.10 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 519.40 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 999.35 +1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 519.40 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 999.35 +1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 966.85 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,610.45 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,957.90 +2.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,774.00 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,466.05 +4.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 519.40 +1.2%

Divi's Laboratories Ltd. FAQ's

What is Divi's Lab share price?
Can I buy Divi's Lab shares now?
What is the Dividend Yield of Divi's Lab?
What is the Market Cap of Divi's Lab?
What are the key metrics to analyse Divi's Lab?
What is the 52 Week High and Low of Divi's Lab?
What is the trend of Divi's Lab share price?